Veracyte (VCYT) News Today $35.94 -1.10 (-2.97%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period State of New Jersey Common Pension Fund D Has $2.09 Million Position in Veracyte, Inc. (NASDAQ:VCYT)State of New Jersey Common Pension Fund D decreased its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 31.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,354 shares of the biotechnology company's stock aftNovember 16 at 4:22 AM | marketbeat.comVeracyte initiated with an Outperform at Wolfe ResearchNovember 16 at 2:52 AM | markets.businessinsider.comVeracyte initiated with an Outperform at Wolfe on growth, margin potentialNovember 16 at 2:52 AM | markets.businessinsider.comVeracyte (NASDAQ:VCYT) Now Covered by Analysts at Wolfe ResearchWolfe Research assumed coverage on Veracyte in a research report on Friday. They set an "outperform" rating and a $50.00 price objective on the stock.November 15 at 8:50 AM | marketbeat.comInsider Sale: CFO Rebecca Chambers Sells Shares of Veracyte Inc (VCYT)November 14 at 10:09 PM | gurufocus.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. lessened its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 13.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,752,383 shares of the biotechnology company's stockNovember 14 at 5:03 AM | marketbeat.comStrategic Focus and Growth Potential Drive Buy Rating for VeracyteNovember 13, 2024 | markets.businessinsider.comArtisan Partners Limited Partnership Bolsters Stake in Veracyte IncNovember 12, 2024 | gurufocus.comVeracyte (NASDAQ:VCYT) Given New $44.00 Price Target at ScotiabankNovember 12, 2024 | americanbankingnews.comPeregrine Asset Advisers Inc. Buys Shares of 137,501 Veracyte, Inc. (NASDAQ:VCYT)Peregrine Asset Advisers Inc. purchased a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 137,501 shares of the biotechnology company's stock, valued at approximately $4,681,000. VeracyNovember 11, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from BrokeragesVeracyte, Inc. (NASDAQ:VCYT - Get Free Report) has earned an average rating of "Moderate Buy" from the eight research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. TheNovember 10, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Price Target Raised to $38.00November 10, 2024 | americanbankingnews.comUBS Group Issues Positive Forecast for Veracyte (NASDAQ:VCYT) Stock PriceNovember 10, 2024 | americanbankingnews.comVeracyte (NASDAQ:VCYT) Stock, Option ChainNovember 10, 2024 | benzinga.comVeracyte’s Strong Market Position and Growth Prospects Lead to Buy Rating and Increased Price TargetNovember 10, 2024 | markets.businessinsider.comScotiabank Reaffirms Their Buy Rating on Veracyte (VCYT)November 10, 2024 | markets.businessinsider.comAEGON ASSET MANAGEMENT UK Plc Decreases Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)AEGON ASSET MANAGEMENT UK Plc cut its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 5.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 714,849 shares of the biotechnology company's stock after selling 44,402November 9, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Shares Gap Up Following Strong EarningsNovember 9, 2024 | americanbankingnews.comVeracyte’s Strong Financial Performance and Growth Potential Lead to Buy Rating and Increased Price TargetNovember 8, 2024 | markets.businessinsider.comVeracyte price target raised to $46 from $43 at UBSNovember 8, 2024 | markets.businessinsider.comVeracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic OutlookNovember 8, 2024 | finance.yahoo.comVeracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Scotiabank Analyst SaysScotiabank raised their price target on shares of Veracyte from $40.00 to $44.00 and gave the company a "sector outperform" rating in a research note on Friday.November 8, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by ARK Investment Management LLCARK Investment Management LLC lowered its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 27.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,920,745 shares of the biotechnology company's stock after sellingNovember 8, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Given New $38.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group boosted their price objective on shares of Veracyte from $34.00 to $38.00 and gave the stock a "buy" rating in a research note on Thursday.November 7, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Shares Gap Up on Better-Than-Expected EarningsVeracyte (NASDAQ:VCYT) Shares Gap Up on Earnings BeatNovember 7, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysNeedham & Company LLC upped their target price on shares of Veracyte from $37.00 to $44.00 and gave the company a "buy" rating in a research report on Thursday.November 7, 2024 | marketbeat.comVeracyte, Inc. (VCYT) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comVeracyte Announces Third Quarter 2024 Financial ResultsNovember 6, 2024 | businesswire.comVeracyte (NASDAQ:VCYT) Hits New 52-Week High - Still a Buy?Veracyte (NASDAQ:VCYT) Hits New 12-Month High - Here's What HappenedNovember 5, 2024 | marketbeat.comWhat To Expect From Veracyte Inc (VCYT) Q3 2024 EarningsNovember 5, 2024 | finance.yahoo.comHarbor Capital Advisors Inc. Acquires 108,148 Shares of Veracyte, Inc. (NASDAQ:VCYT)Harbor Capital Advisors Inc. increased its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 172.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,834 shares of the biotecNovember 4, 2024 | marketbeat.comAssenagon Asset Management S.A. Raises Position in Veracyte, Inc. (NASDAQ:VCYT)Assenagon Asset Management S.A. grew its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 127.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,455 shares of the biotechnologNovember 3, 2024 | marketbeat.com127,190 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Rice Hall James & Associates LLCRice Hall James & Associates LLC bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 127,190 shares of the biotechnology company's stocNovember 1, 2024 | marketbeat.comAMI Asset Management Corp Sells 19,514 Shares of Veracyte, Inc. (NASDAQ:VCYT)AMI Asset Management Corp lowered its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 22.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 66,882 shares of the biotechnology compOctober 30, 2024 | marketbeat.comVeracyte (VCYT) to Release Quarterly Earnings on WednesdayVeracyte (NASDAQ:VCYT) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636514)October 30, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) PT Raised to $40.00Leerink Partners lifted their price target on shares of Veracyte from $35.00 to $40.00 and gave the company an "outperform" rating in a report on Thursday.October 17, 2024 | marketbeat.comUBS Initiates Coverage of Veracyte (VCYT) with Buy RecommendationOctober 17, 2024 | msn.comVeracyte to Release Third Quarter 2024 Financial Results on November 6, 2024October 16, 2024 | businesswire.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from AnalystsShares of Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) have received an average rating of "Moderate Buy" from the six brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and five have issued a buy rating on the cOctober 16, 2024 | marketbeat.comIs Veracyte, Inc. (NASDAQ:VCYT) Trading At A 31% Discount?October 16, 2024 | finance.yahoo.comUBS Group Initiates Coverage on Veracyte (NASDAQ:VCYT)UBS Group began coverage on Veracyte in a research note on Wednesday. They set a "buy" rating and a $43.00 target price for the company.October 16, 2024 | marketbeat.comExchange Traded Concepts LLC Decreases Stake in Veracyte, Inc. (NASDAQ:VCYT)Exchange Traded Concepts LLC cut its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 31.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,843 shares of the biotechnology company's stock aftOctober 15, 2024 | marketbeat.comCubist Systematic Strategies LLC Has $736,000 Holdings in Veracyte, Inc. (NASDAQ:VCYT)Cubist Systematic Strategies LLC lessened its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 80.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,946 shares of the biotechnology company's stock afterOctober 12, 2024 | marketbeat.comGuggenheim Initiates Coverage of Veracyte (VCYT) with Buy RecommendationOctober 12, 2024 | msn.comVeracyte Inc (VCYT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised GuidanceOctober 10, 2024 | finance.yahoo.comVeracyte (NASDAQ:VCYT) Now Covered by Analysts at GuggenheimGuggenheim began coverage on shares of Veracyte in a research report on Thursday. They set a "buy" rating and a $40.00 price target on the stock.October 10, 2024 | marketbeat.comVeracyte (NASDAQ:VCYT) Shares Up 4.9% - What's Next?Veracyte (NASDAQ:VCYT) Shares Up 4.9% - Should You Buy?October 7, 2024 | marketbeat.comNew Data Presented at ASTRO 2024 Show that Veracyte's Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American MenOctober 4, 2024 | stockhouse.comHere's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth TodayOctober 4, 2024 | msn.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC lowered its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 80.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,946 shares of the biotechnology company's stock after selOctober 4, 2024 | marketbeat.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼0.830.55▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼184▲VCYT Articles Average Week Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PACS Group News Today Hims & Hers Health News Today Sotera Health News Today Option Care Health News Today Surgery Partners News Today BrightSpring Health Services News Today Guardant Health News Today LifeStance Health Group News Today Ardent Health Partners News Today Concentra Group Holdings Parent News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCYT Stock Alerts